Clinical Trials Directory

Trials / Completed

CompletedNCT05015322

Comparison of the Effectiveness of the Ultrasound Guided Injections in Patients With Shoulder Impingement Syndrome

Comparison of the Effectiveness of the Ultrasound Guided Subacromial, Acromioclavicular With Subacromial Injection and Suprascapular Nerve Block in Patients With Shoulder Impingement Syndrome ; A Randomized Controlled, Single Blind, Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
88 (actual)
Sponsor
Bursa Yuksek Ihtisas Training and Research Hospital · Other Government
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Shoulder pain, which is the third most common cause of musculoskeletal pain, has different etiologies. Muscle, bone structures and connective tissue pathologies can cause shoulder pain. Impingement syndrome (IS), which can cover many terms such as rotator cuff disorders, tendinitis and tears, is one of the most common pathologies of shoulder pain.

Detailed description

The hypothesis of this study was that injection types including ACJ would increase treatment efficacy.Therefore, this study investigated the six-month follow-up results of patients undergoing SA injection and SSNB and those receiving SA and ACJ injection.

Conditions

Interventions

TypeNameDescription
DRUGbupivacaine and methylprednisolone5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area
DRUGbupivacaine and methylprednisolone5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area for the subacromial+acromioclavicular joint injection. In addition, 2 mL of 20 mg methylprednisolone and the same concentration of local anaesthetic were injected into the acromioclavicular joint
DRUGbupivacaine and methylprednisolonesuprascapular nerve block was administered with a mixture of 10 mL of 0.25% bupivacaine and 40 mg methylprednisolone

Timeline

Start date
2017-01-01
Primary completion
2021-01-01
Completion
2021-01-01
First posted
2021-08-20
Last updated
2021-08-20

Source: ClinicalTrials.gov record NCT05015322. Inclusion in this directory is not an endorsement.